華測導航(300627.SZ):截至目前,公司車規級產品累計交付數量突破30萬套
格隆匯5月7日丨華測導航(300627.SZ)在投資者關係表示,相較於機器人與自動駕駛板塊的其他業務,乘用車自動駕駛相關產品單價相對較低,短期對該板塊收入增長的貢獻有限。公司在乘用車自動駕駛業務上取得了良好的突破,已被指定為多家車企的自動駕駛位置單元業務定點供應商,部分相關車型已實現量產,截至目前,公司車規級產品累計交付數量突破30萬套。公司將繼續積極佈局車規級芯片、全球 SWAS
廣域增強系統,持續投入優化核心算法,為客户提供更有競爭力的產品與解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.